Surgeon

Robotics is being called the “fourth industrial revolution.” For some cardiothoracic surgeons, robotics means smaller, faster, and easier, resulting in patients getting out of the hospital sooner, having less pain, and returning to function faster. For others, the jury is still out on whether or not robotics will add long-term value, especially if surgeons face potential carpal tunnel injuries, back pain, and cervical stenosis. David T. Cooke, MD, moderates a panel discussion with Robert E. Merritt, MD, Lana Y. Schumacher, MD, Melanie A. Edwards, MD, and Inderpal S. Sarkaria, MD.

For cardiothoracic surgeons who are hoping to advance in their careers, it’s often difficult to balance clinical work with the scholarly activities that are necessary for promotion in a modern academic medicine environment. Ourania A. Preventza, MD, and colleagues including Himanshu J. Patel, MD, Elaine E. Tseng, MD, and Sunil Singhal, MD, provide insight on the processes required and tips to help young surgeons successfully get to the next step.

Cardiothoracic surgeons are studying the use of artificial intelligence (AI) and machine learning (ML) to improve risk prediction in the hopes that patient outcomes also will improve. Arman Kilic, MD, and Ara A. Vaporciyan, MD, along with medical student Brian Ayers, discuss what AI and ML mean, how it can uncover previously unknown relationships in medical data, and how it can be used to assist the surgeon in the operating room.

More than 100,000 people in the United States currently are waiting for a lifesaving organ transplant, including 5,000 people on the transplant list for a heart and/or lungs, according to the United Network for Organ Sharing. Although some will die before they receive a transplant, surgeons and research teams are making great strides in expanding the pool of viable organs. Zachary N. Kon, MD, moderates a discussion with Ashish S. Shah, MD, Matthew G.